BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ferrarese A, Zanetto A, Germani G, Burra P, Senzolo M. Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension. World J Hepatol 2016; 8(24): 1012-1018 [PMID: 27648153 DOI: 10.4254/wjh.v8.i24.1012]
URL: https://www.wjgnet.com/1948-5182/full/v8/i24/1012.htm
Number Citing Articles
1
Wolfgang Kreisel, Denise Schaffner, Adhara Lazaro, Jonel Trebicka, Irmgard Merfort, Annette Schmitt-Graeff, Peter Deibert. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal HypertensionInternational Journal of Molecular Sciences 2020; 21(17): 6223 doi: 10.3390/ijms21176223
2
Alberto Zanetto, Sarah Shalaby, Paolo Feltracco, Martina Gambato, Giacomo Germani, Francesco Paolo Russo, Patrizia Burra, Marco Senzolo. Recent Advances in the Management of Acute Variceal HemorrhageJournal of Clinical Medicine 2021; 10(17): 3818 doi: 10.3390/jcm10173818
3
Juan Carlos Garcia-Pagan, Claire Francoz, Sara Montagnese, Marco Senzolo, Rajeshwar P. Mookerjee. Management of the major complications of cirrhosis: Beyond guidelinesJournal of Hepatology 2021; 75: S135 doi: 10.1016/j.jhep.2021.01.027
4
Faris Qaqish, Reem Dimachkie, Roula Sasso, Jeffrey Loeffler, Mohammed Hasan, Shabnam Deghani, Ahmad Abou Yassine, Liliane Deeb. Safety of Nonselective Beta-Blockers in Decompensated Liver Cirrhosis and Their Role in Inducing Hepatorenal SyndromeCureus 2024;  doi: 10.7759/cureus.58296
5
Ji-Yao Sheng, Zi-Fan Meng, Qiao Li, Yong-Sheng Yang. Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertensionHepatobiliary & Pancreatic Diseases International 2024; 23(1): 4 doi: 10.1016/j.hbpd.2023.08.003